Login  /  Register  | 3 premium articles left before you must register.
Join | Rewards | Advertise

Amarin seeks expanded Vascepa use

Published 02/28/2013 12:00 AM
Updated 02/28/2013 12:08 AM

Amarin Corp. plc, an Irish company with research headquarters in Groton, said Tuesday that it has submitted to the U.S. Food and Drug Administration an application to expand the market for its new heart medication Vascepa.

The supplemental application seeks approval to target millions of new potential Vascepa patients who have elevated levels of a certain type of fat in the blood known as triglycerides. The FDA already has approved Vascepa for patients with very high triglyceride levels.

Amarin said it expects the FDA to decide on whether to review the supplemental application within a month and a half.

- Lee Howard

Also of Interest

Town News

Visit Zip06
what is zip06? | my profile
Submit Your:  Submit Your News Submit Your Photos Submit Your Events

MORE

Have you spotted a celebrity?

Have you ever spotted any celebrities around the region? Tell us who, where and when via email to tips@theday.com. Include photos if possible.

MORE QUERIES
Most Recent Poll
Unless Congress and the White House act, $85 billion in automatic federal spending cuts will take effect Friday. Are you worried about the impact sequestration will have on you?
Yes, I'm worried about the impact on the region's defense industry.
25%
Yes, I rely on some of the social programs targeted for big cuts.
4%
No, I'm just sick of the failure of Congress and the White House to lead effectively.
68%
Sequestration? Never heard of it.
3%
Number of votes: 1197

Popular on theday.com